Genomic Intelligence
PrivateLast Round
Accelerator
Jan 1, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Genomic Intelligence operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was an Accelerator round in January 2026.
Genomic Intelligence is a biotechnology and artificial intelligence company that builds ultra-long-context genomic foundation models to predict disease risk, explain heritability, and design actionable edits from whole-genome and multi-omics data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Platform-as-a-Service
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomic Intelligence Comparables
Compare Genomic Intelligence with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blank Bio | 83% | |
| Cassidy Bio | 81% | |
| Helical | 78% |
For institutional investors. Book with your work email.
Genomic Intelligence Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Genomic Intelligence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NextView Ventures | Accelerator |
| Caelestinus | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Funding round led by NextView Ventures and Caelestinus.
For institutional investors. Book with your work email.
Genomic Intelligence Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genomic Intelligence's valuation, stock price, and market status.
Is Genomic Intelligence a public or private company?
Genomic Intelligence is a private company.
What is the current stock price of Genomic Intelligence?
Genomic Intelligence is a private company, so its shares have no public market price. Caplight tracks Genomic Intelligence's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genomic Intelligence worth (valuation)?
Valuation information for Genomic Intelligence is not publicly available.
Can I buy Genomic Intelligence stock?
Genomic Intelligence shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genomic Intelligence's last funding round?
Genomic Intelligence's most recent funding round was Accelerator on January 1, 2026.
Who are the main investors in Genomic Intelligence?
Key investors in Genomic Intelligence include NextView Ventures, Caelestinus.
Will Genomic Intelligence IPO soon?
No public IPO plans have been announced for Genomic Intelligence.
How can I track Genomic Intelligence secondary market activity?
Caplight tracks bids, offers, and trades in Genomic Intelligence's shares on secondary markets.